The choice of jet nebulizer, nebulizing flow, and addition of albuterol affects the output of tobramycin aerosols

Chest

Volumn 111, Issue 5, 1997, Pages 1206-1212

  Coates, Allan L ^a,c   MacNeish, Clair F ^a   Meisner, Dale ^b   Kelemen, Susan ^b   Thibert, Roch ^b   MacDonald, Jane ^a   Vadas, Elizabeth ^b  

^a MONTREAL CHILDREN S HOSPITAL   (Canada)

^b MERCK FROSST CENTRE FOR THERAPEUTIC RESEARCH   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

aerosols; antibiotics; cystic fibrosis; Pseudomonas aeruginosa; tobramycin

Indexed keywords

SALBUTAMOL; SODIUM CHLORIDE; TOBRAMYCIN;

ARTICLE; COMPARATIVE STUDY; CYSTIC FIBROSIS; DRUG DISTRIBUTION; DRUG EFFICACY; LASER DIFFRACTION; MEDICAL NEBULIZER; MINIMUM INHIBITORY CONCENTRATION; NEBULIZATION; NONHUMAN; OSMOLARITY; PARTICLE SIZE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SURFACE TENSION;

EID: 0030964331     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.111.5.1206     Document Type: Article

References (36)

1. Hodson ME, Penketh ARL, Batten JC. Aerosol carbenicillin and gentamicin treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis. Lancet 1981; 2:1137-39
2. MacLusky IB, Gold R, Corey ML, et al. Long-term effects of inhaled tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa. Pediatr Pulmonol 1989; 7:42-48
3. Nathanson I, Cropp GJA, Li P, et al. Effectiveness of aerosolized gentamicin in cystic fibrosis [abstract]. Cystic Fibrosis Club Abstracts 1985; 26:145
4. Kun P, Landan LI, Phelan PD. Nebulized gentamycin in children and adolescents with cystic fibrosis. Aust Paediatr J 1984; 20:43-5
5. Schaad UB, Wedgwood-Krucko J, Suter S, et al. Efficacy of inhaled amikacin as adjunct to intravenous combination therapy (ceftazidime and amikacin) in cystic fibrosis. J Pediatr 1987; 111:599-605
6. Ramsey BW, Dorkin HL, Eisenberg JD, et al. Efficacy of aerosolized tobramycin in patients cystic fibrosis. N Engl J Med 1993: 328:1740-46
7. Wall MA, Terry AB, Eisenberg JD, et al. Inhaled antibioties in cystic fibrosis. Lancet 1983; 2:1325
8. Smith AL, Ramsey BW, Hedges DL, et al. Safety of aerosolized tobramycin administration for 3 months to patients with cystic fibrosis. Pediatr Pulmonol 1989; 7:265-71
9. Steinkamp G, Tummler B, Gappa M. et al. Long-term tobramycin aerosol therapy in cystic fibrosis. Pediatr Pulmonol 1989; 6:91-8
10. Stead RJ, Hodson ME, Batten JC. Inhaled ceftazadime compared with gentamicin and carbenicillin in older patients with cystic fibrosis infected with Pseudomonas aeruginosa. Br J Dis Chest 1987; 81:272-79
11. Dennis JH, Stenton SC, Beach JR, et al. Jet and ultrasonic nebuliser output: use of a new method for direct measurement of aerosol output. Thorax 1990; 45:728-32
12. Weber A, Smith AL, Williams-Warren J, et al. Nebulizer delivery of tobramycin to the lower respiratory tract. Pediatr Pulmonol 1994; 17:331-39
13. Alderson PO, Secker-Walker RH. Strominger DB, et al. Pulmonary deposition of aerosols in children with cystic fibrosis. J Pediatr 1974; 84:479-84
14. Ilowite JS, Gorvoy JD, Smaldone GC. Quantitative deposition of aerosolized gentamycin in cystic fibrosis. Am Rev Respir Dis 1987; 136:1445-49
15. Brain JD, Valberg PA. Deposition of aerosol in the respiratory tract - state of the art. Am Rev Respir Dis 1979; 120:1325-73
16. Dolovich MB. Physical principles underlying aerosol therapy. J Aerosol Med 1989; 2:171-86
17. Desmond KJ, Allen PD, Demizio DL, et al. The contribution of the fast and slow compartments to airflow limitation in children with asthma [abstract]. Am Rev Respir Dis 1993; 147:A128
18. Knowles MR, Church NL, Waltner WE, et al. A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis. N Engl J Med 1990; 322:1189-94
19. Newman SP, Pellow PGD, Clay MM, et al. Evaluation of jet nebulisers for use with gentamicin solution. Thorax 1985; 40:671-76
20. Clay MM, Pavia D, Newman SP, et al. Factors influencing the size distribution of aerosols from jet nebulisers. Thorax 1983; 38:755-59
21. Kradjan WA, Lakshminarayan S. Efficiency of air compressor-driven nebulizers. Chest 1985; 87:512-15
22. Wood JA, Wilson RSE, Bray C. Changes in salbutamol concentration in the reservoir solution of a jet nebulizer. Br J Dis Chest 1986; 80:164-69
23. Mukhopadhyay S, Staddon GE, Eastman C, et al. The quantitative distribution of nebulized antibiotie in the lung in cystic fibrosis. Respir Med 1994; 88:203-11
24. Fuchs HJ, Borowitz DS, Christiansen DH, et al. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. N Engl J Med 1994; 331:637-42
25. Ramsey BW, Astley SJ, Aitken ML. et al. Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuelease in patients with cystic fibrosis. Am Rev Respir Dis 1993; 148:145-51
26. Knoch M, Wunderlich E, Geldner S. A nebulizer system for highly reproducible aerosol delivery. J Aerosol Med 1994; 3:229-37
27. National Committee for Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically (approved standard, M7-A2). Villanova, Pa: National Committee for Clinical Laboratory Standards, 1990
28. Adamson AW. Wilhelmy slide method. In: Physical chemistry of surfaces. 4th ed. New York: John Wiley, 1982:24-6
29. O'Callaghan C, Clarke AR, Milner AD. Inaccurate calculation of drug output from nebulisers. Eur J Pediatr 1989; 148:473-74
30. MacNeish CF, Meisner D, Kelemen S, et al. A comparison of pulmonary availability between Ventolin nebules and Ventolin Respirator Solution. Chest 1997; 111:204-08
31. Ho KKL, Kellaway IW, Tredree R. Particle size analysis of nebulised aerosols using Fraunhofer laser diffraction and inertial compaction methods [abstract]. J Pharm Pharmacol 1986; 38:26
32. Knoch M, Wunderlich E, Roth C, et al. Output characterization of medical nebulizers. J Aerosol Sci 1994; 25:S439-40
33. Swift DL. Aerosol characteristics and generation. In: Moren F, Dolovich MB, Newhouse MT, et al, eds. Aerosols in medicine: principles, diagnosis and therapy. New York: Elsevier Science (Biomedical Division), 1985; 53-76
34. Tounesen P, Stovring S. Positive expiratory pressure (PEP) as lung physiotherapy in cystic fibrosis: a pilot study. Eur J Respir Dis 1984; 65:419-22
35. Clay MM, Pavia D, Newman SP, et al. Assessment of jet nebulisers for lung aerosol therapy. Lancet 1983; 2:592-94
36. Collis GG, Cole CH, LeSouëf PN. Dilution of nebulised aerosols by air entrainment in children. Lancet 1990; 336:341-43